Skip to main content
Show full summary

Lord Balfe to ask Her Majesty's Government what assessment they have made of reports that, following its acquisition by a Swiss private equity firm, Essential Pharma has increased the price of one of its branded lithium carbonate tablets from £3.22 to £87.00 a packet, and withdrawn its other brand of lithium carbonate tablet; what estimate they have made of the time it would take to obtain a marketing authorisation for a replacement; and what plans they have to speed up that process.  HL8360

Question HL8360: tabled on 22 September 2020 and due for answer by 6 October 2020

This type of business sits within the Questions & Statements category.

This question has been answered by the relevant Government Department.

Question text

To ask Her Majesty's Government what assessment they have made of reports that, following its acquisition by a Swiss private equity firm, Essential Pharma has increased the price of one of its branded lithium carbonate tablets from £3.22 to £87.00 a packet, and withdrawn its other brand of lithium carbonate tablet; what estimate they have made of the time it would take to obtain a marketing authorisation for a replacement; and what plans they have to speed up that process.
Legend for business item text
Item that is new or altered.
[I] Indicates that the member concerned has a relevant registered interest.
* Item is an oral question.
Numbers starting HL are unique identifiers for written questions, Bills or papers.

Member's Registered Interests

There are no interests to show.